Search by Drug Name or NDC

    NDC 54859-0603-02 Tusnel DM 2.5; 25; 7.5 mg/mL; mg/mL; mg/mL Details

    Tusnel DM 2.5; 25; 7.5 mg/mL; mg/mL; mg/mL

    Tusnel DM is a ORAL SOLUTION/ DROPS in the HUMAN OTC DRUG category. It is labeled and distributed by Llorens Pharmaceutical International Division. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 54859-0603
    Product ID 54859-603_a3f45673-555c-46e7-9afe-7e6276f1b327
    Associated GPIs 43997303320973
    GCN Sequence Number 068312
    GCN Sequence Number Description guaifenesin/DM/pseudoephedrine DROPS 2.5-7.5/ML ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 31074
    HICL Sequence Number 000222
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PSEUDOEPHEDRINE HCL
    Brand/Generic Brand
    Proprietary Name Tusnel DM
    Proprietary Name Suffix Pediatric
    Non-Proprietary Name Dextromethorphan, Guiafenesin, Pseudoephedrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION/ DROPS
    Route ORAL
    Active Ingredient Strength 2.5; 25; 7.5
    Active Ingredient Units mg/mL; mg/mL; mg/mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name Llorens Pharmaceutical International Division
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 54859-0603-02 (54859060302)

    NDC Package Code 54859-603-02
    Billing NDC 54859060302
    Package 60 mL in 1 BOTTLE, DROPPER (54859-603-02)
    Marketing Start Date 1993-01-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL d915eab8-013e-4ce3-b358-0d531e5ca1ba Details

    Revised: 12/2020